
AstraZeneca signs strategic partnership with Beijing; invests $2.5bn
The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to help make vaccines; there is also investment into AI. 
Mar 24, 2025
.jpg&c=1&h=298&q=80&v=20251031&w=530)
.jpg&c=1&h=298&q=80&v=20251031&w=530)
